After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Pacira BioSciences Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Pacira BioSciences Inc is $1.19B. A total of 0.76 million shares were traded on the day, compared to an average of 959.41K shares.
In the most recent transaction, GAUGLER DARYL bought 500 shares of PCRX for 23.25 per share on Mar 06 ’25. In a previous transaction on Jan 06 ’25, SLONIN JONATHAN sold 879 shares at 18.40 per share. PCRX shares that Chief Medical Officer owns now total 93,444.
Among the insiders who bought shares, SLONIN JONATHAN acquired of 879 shares on Jan 06 ’25 at a per-share price of $18.40. In another insider transaction, GAUGLER DARYL sold 500 shares at $19.76 per share on Dec 13 ’24. Company shares held by the Chief Operating Officer now total 115,200.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PCRX has a high of $31.67 and a low of $11.16.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PCRX’s latest balance sheet shows that the firm has $656.41M in Cash & Short Term Investments as of fiscal 2021. There were $1.13B in debt and $521.12M in liabilities at the time. Its Book Value Per Share was $17.25, while its Total Shareholder’s Equity was $730.41M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PCRX is Buy with a score of 3.38.
